Biotech news
Pharma
Johnson & Johnson has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy. 22 February 2018
Americas
Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”. 20 February 2018
Americas
Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion. 19 February 2018
Americas
Japan-based Astellas Pharma has acquired US-based Universal Cells in a move that will allow it to develop universal donor cell technology. 16 February 2018
Americas
Biotechnology company United Therapeutics has reached a settlement with Actavis Laboratories to resolve a dispute over patents concerning a blood pressure drug. 16 February 2018
Americas
Bristol-Myers Squibb has agreed to pay $1.85 billion for an immuno-oncology programme. 15 February 2018
Americas
French cell therapy company Cellectis has announced plans to make two CRISPR patents, which were recently granted by the US Patent and Trademark Office, available for licensing. 14 February 2018
Americas
Companies researching and commercialising drugs for rare diseases face unusual challenges in protecting their inventions, as Michael Yamauchi, director and patent counsel at Alexion Pharmaceuticals, tells LSIPR in an interview. 8 February 2018
Americas
Teva sued Eli Lilly yesterday in a bid to protect its IP rights covering “breakthrough treatments for migraine headaches”. 7 February 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday affirmed a district court’s findings that Hospira doesn’t infringe two patents owned by biopharma firm The Medicines Company, while remanding an on-sale bar question. 7 February 2018